These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 15950952

  • 1. HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha.
    Place RF, Noonan EJ, Giardina C.
    Biochem Pharmacol; 2005 Aug 01; 70(3):394-406. PubMed ID: 15950952
    [Abstract] [Full Text] [Related]

  • 2. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity.
    Yin L, Laevsky G, Giardina C.
    J Biol Chem; 2001 Nov 30; 276(48):44641-6. PubMed ID: 11572859
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha.
    Adam E, Quivy V, Bex F, Chariot A, Collette Y, Vanhulle C, Schoonbroodt S, Goffin V, Nguyên TL, Gloire G, Carrard G, Friguet B, De Launoit Y, Burny A, Bours V, Piette J, Van Lint C.
    Mol Cell Biol; 2003 Sep 30; 23(17):6200-9. PubMed ID: 12917341
    [Abstract] [Full Text] [Related]

  • 4. Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells.
    Domingo-Domènech J, Pippa R, Tápia M, Gascón P, Bachs O, Bosch M.
    Breast Cancer Res Treat; 2008 Nov 30; 112(1):53-62. PubMed ID: 18064564
    [Abstract] [Full Text] [Related]

  • 5. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
    Ashburner BP, Westerheide SD, Baldwin AS.
    Mol Cell Biol; 2001 Oct 30; 21(20):7065-77. PubMed ID: 11564889
    [Abstract] [Full Text] [Related]

  • 6. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.
    Quivy V, Adam E, Collette Y, Demonte D, Chariot A, Vanhulle C, Berkhout B, Castellano R, de Launoit Y, Burny A, Piette J, Bours V, Van Lint C.
    J Virol; 2002 Nov 30; 76(21):11091-103. PubMed ID: 12368351
    [Abstract] [Full Text] [Related]

  • 7. Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells.
    Usami M, Kishimoto K, Ohata A, Miyoshi M, Aoyama M, Fueda Y, Kotani J.
    Nutr Res; 2008 May 30; 28(5):321-8. PubMed ID: 19083427
    [Abstract] [Full Text] [Related]

  • 8. Contribution of disruption of the nuclear factor-kappaB pathway to induction of apoptosis in human leukemia cells by histone deacetylase inhibitors and flavopiridol.
    Gao N, Dai Y, Rahmani M, Dent P, Grant S.
    Mol Pharmacol; 2004 Oct 30; 66(4):956-63. PubMed ID: 15235103
    [Abstract] [Full Text] [Related]

  • 9. Proteasome inhibitors induce inhibitory kappa B (I kappa B) kinase activation, I kappa B alpha degradation, and nuclear factor kappa B activation in HT-29 cells.
    Németh ZH, Wong HR, Odoms K, Deitch EA, Szabó C, Vizi ES, Haskó G.
    Mol Pharmacol; 2004 Feb 30; 65(2):342-9. PubMed ID: 14742676
    [Abstract] [Full Text] [Related]

  • 10. Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer.
    Denlinger CE, Keller MD, Mayo MW, Broad RM, Jones DR.
    J Thorac Cardiovasc Surg; 2004 Apr 30; 127(4):1078-86. PubMed ID: 15052205
    [Abstract] [Full Text] [Related]

  • 11. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
    Hu J, Colburn NH.
    Mol Cancer Res; 2005 Feb 30; 3(2):100-9. PubMed ID: 15755876
    [Abstract] [Full Text] [Related]

  • 12. Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF kappa B signalling.
    Schwab M, Reynders V, Loitsch S, Steinhilber D, Stein J, Schröder O.
    Mol Immunol; 2007 Jul 30; 44(15):3625-32. PubMed ID: 17521736
    [Abstract] [Full Text] [Related]

  • 13. Regulation of monocarboxylate transporter 1 (MCT1) promoter by butyrate in human intestinal epithelial cells: involvement of NF-kappaB pathway.
    Borthakur A, Saksena S, Gill RK, Alrefai WA, Ramaswamy K, Dudeja PK.
    J Cell Biochem; 2008 Apr 01; 103(5):1452-63. PubMed ID: 17786924
    [Abstract] [Full Text] [Related]

  • 14. Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes.
    Chabane N, Zayed N, Afif H, Mfuna-Endam L, Benderdour M, Boileau C, Martel-Pelletier J, Pelletier JP, Duval N, Fahmi H.
    Osteoarthritis Cartilage; 2008 Oct 01; 16(10):1267-74. PubMed ID: 18417374
    [Abstract] [Full Text] [Related]

  • 15. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.
    Imre G, Gekeler V, Leja A, Beckers T, Boehm M.
    Cancer Res; 2006 May 15; 66(10):5409-18. PubMed ID: 16707469
    [Abstract] [Full Text] [Related]

  • 16. Modulation of complement component (C3 and factor B) biosynthesis by a histone deacetylase inhibitor in human intestinal epithelial cells.
    Andoh A, Fujiyama Y, Shimada M, Bamba T.
    Int J Mol Med; 2000 Jul 15; 6(1):51-4. PubMed ID: 10851266
    [Abstract] [Full Text] [Related]

  • 17. Synergy between deacetylase inhibitors and IL-1beta in activation of the serum amyloid A2 gene promoter.
    Blais M, Désilets A, Asselin C.
    DNA Cell Biol; 2005 Apr 15; 24(4):209-17. PubMed ID: 15812237
    [Abstract] [Full Text] [Related]

  • 18. Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells.
    Chen Y, Shu W, Chen W, Wu Q, Liu H, Cui G.
    Basic Clin Pharmacol Toxicol; 2007 Dec 15; 101(6):427-33. PubMed ID: 17927689
    [Abstract] [Full Text] [Related]

  • 19. Proteasome inhibition improves fractionated radiation treatment against non-small cell lung cancer: an antioxidant connection.
    Grimes KR, Daosukho C, Zhao Y, Meigooni A, St Clair W.
    Int J Oncol; 2005 Oct 15; 27(4):1047-52. PubMed ID: 16142322
    [Abstract] [Full Text] [Related]

  • 20. Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1β signaling in osteoarthritis fibroblast-like synoviocytes.
    Wang JH, Shih KS, Wu YW, Wang AW, Yang CR.
    Osteoarthritis Cartilage; 2013 Dec 15; 21(12):1987-96. PubMed ID: 24107356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.